Article: Mingzhu Group to sell stake in pharma subsidiary.

Mingzhu Group to sell stake in pharma subsidiary

Shanghai. May 12. INTERFAX-CHINA - Guangdong Mingzhu Group Co. Ltd. will sell its majority stake in a pharmaceutical company due to poor business performance, it announced on May 12.

According to the announcement, Mingzhu Group's board of directors has agreed to sell the company's 88.30 percent stake in Guangdong Mingzhu Pharmaceutical Co. Ltd. for a minimum of RMB 50.71 million ($7.43 million) as the subsidiary had dragged down its parent company's profitability.

Mingzhu Pharma, a traditional Chinese medicine (TCM) joint venture founded in 1997, has been operating on narrow profit margins in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!